Skip to main content

Table 2 Data collection by visit

From: The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

Months from BL BL T1 F1 T2 F2 T3 F3 F4 F5 F6
0 0.5 1 1.5 2 2.5 3 4 5 6
Procedures
 Consent X X X X X X X X X X
 History, or interim history X X X X X X X X X X
 Demographics X - - - - - - - - -
 Review of inclusion/exclusion X - - - - - - - - -
 Psychosocial intervention X - X - X - X X X X
 Dispensing of study drug X - X - X - X X X -
 Review visit schedule X X X X X X X X X X
 Review of compliance - X X X X X X X X X
Assessments
 NPI X - X - X - X X X X
 mADCS-CGIC X - X - X - X X X X
 DAIR X - X - X - X X X X
 ADL X - - - X - - X - X
 Dependence Scale X - - - X - - X - X
 Cognitive battery X - - - X - - X - X
 EQ-5D-5 L X - - - - - X - - X
 RUD-lite X - - - - - X - - X
 Diagnostic criteria for apathy X - - - - - - - - -
Safety measurements
 Vital signs X - X - X - X X X X
 Electrolyte panel X - X - X - X X X X
 Adverse events X X X X X X X X X X
 Review ECG X - X - X - X X X X
  1. BL baseline visit, F scheduled follow-up visits, T scheduled telephone contact, NPI Neuropsychiatric Inventory, mADCS-CGIC modified AD Cooperative Study Global Impression of Change, DAIR Dementia Apathy Interview and Rating, ADL Activities of Daily Living, EQ-5D-5 L Euro Quality of Life, RUD-lite Resource Utilization in Dementia-Lite, ECG electrocardiogram